預測腫瘤學的大膽舉動：癌症研究中的3.444億美元的數字資產國庫

預測腫瘤學開創了癌症研究的新時代，該時代通過推出了一家耗資3.444億美元的數字資產財政部，重點是Aethir的Ath代幣，旨在徹底改變AI基礎設施。

Predictive Oncology's Bold Move: A $344.4 Million Digital Asset Treasury in Cancer Research

預測腫瘤學的大膽舉動：癌症研究中的3.444億美元的數字資產國庫

Hold on to your hats, folks! Predictive Oncology is shaking things up in the world of cancer research. They're diving headfirst into the digital asset realm with a whopping $344.4 million treasury, primarily focused on Aethir's ATH token. This isn't your grandma's cancer research anymore; it's the future, baby!

抓住你的帽子，伙計們！預測腫瘤學正在癌症研究領域震撼。他們以高達3.44億美元的財政部的價格首先跳入數字資產領域，主要集中在Aethir的Ath令牌上。這不是您奶奶的癌症研究；這是未來，寶貝！

What's the Big Deal?

有什麼大不了的？

On September 29, 2025, Predictive Oncology (NASDAQ: POAI) announced its groundbreaking digital asset treasury strategy. This makes them the first Nasdaq-listed company to embrace tokens from a Decentralized Physical Infrastructure Network (DePIN). Think blockchain meets real-world computing resources. It's like something out of a sci-fi movie, but it's happening now!

2025年9月29日，預測腫瘤學（NASDAQ：POAI）宣布了其開創性的數字資產國庫策略。這使他們成為第一家從分散的物理基礎設施網絡（DEPIN）中擁抱令牌的納斯達克上市公司。認為區塊鏈符合現實世界的計算資源。這就像一部科幻電影中的事情，但現在正在發生！

The ATH Token: A Key Player

ATH象徵：關鍵球員

Aethir operates a decentralized cloud network, providing GPU infrastructure for AI applications, high-performance computing, and gaming. Their ATH token is currently trading around $0.06, with a market cap of about $2.3 billion. After the announcement, trading volume for ATH skyrocketed by over 330% in just 24 hours. Talk about a buzz!

Aethir運營一個分散的云網絡，為AI應用程序，高性能計算和遊戲提供GPU基礎架構。他們的ATH代幣目前的交易約為0.06美元，市值約為23億美元。宣佈公告後，ATH的交易量在短短24小時內飛速增長了330％以上。談論嗡嗡聲！

Why This Matters for Cancer Research

為什麼這對癌症研究很重要

Predictive Oncology isn't just throwing money at crypto; they're strategically aligning with Aethir to bolster AI-driven drug discovery. Their AI platform, PEDAL, boasts a 92% accuracy in predicting tumor response to drug compounds. With Aethir's GPU network, they can accelerate this process, potentially leading to faster and more effective cancer treatments. It’s like giving cancer research a turbo boost!

預測腫瘤學不只是向加密貨幣扔錢。他們從戰略上與Aethir保持一致，以增強AI驅動的藥物發現。他們的AI平台踏板在預測腫瘤對藥物化合物的反應方面具有92％的精度。借助Aethir的GPU網絡，它們可以加速這一過程，可能導致更快，更有效的癌症治療。這就像給癌症研究提升了！

The Financial Jolt

財務震動

The market responded with enthusiasm. Predictive Oncology's stock price jumped over 70% following the announcement, reaching its highest level since March. This move provides a much-needed financial boost after a couple of challenging years. They are not alone, though. Other small-cap companies are dipping their toes in digital assets too. But, like Standard Chartered analysts warn, it could be a valuation squeeze if everyone jumps on the bandwagon.

市場充滿熱情。宣布後，預測腫瘤學的股價上漲了70％以上，達到了3月以來的最高水平。經過幾年充滿挑戰的年份，此舉為急需的財務增長。他們並不孤單。其他小型公司也在將其腳趾浸入數字資產中。但是，就像標準特許分析師警告說，如果每個人都跳上潮流，這可能是一個估值。

A Strategic Compute Reserve

戰略計算儲備

The company is planning to establish a Strategic Compute Reserve. This reserve aims to strengthen Aethir’s deployment capacity while expanding Predictive Oncology’s business scope. The integration also signals a long-term commitment to AI infrastructure and tokenized compute economics.

該公司計劃建立戰略計算儲備。該儲備金旨在增強Aethir的部署能力，同時擴大預測性腫瘤學的業務範圍。該集成還表示對AI基礎設施和令牌化計算經濟學的長期承諾。

My Two Cents

我的兩分錢

Look, I'm no financial guru, but this move by Predictive Oncology seems pretty darn smart. By integrating digital assets into their strategy, they're not just keeping up with the times; they're blazing a trail. It's a bold bet, sure, but one that could revolutionize cancer research. This is what happens when you think outside the box, people! It’s also really impressive to see how they have set up a structure that would allow for Predictive Oncology to participate as an operator on the Aethir ecosystem through its planned holdings of ATH tokens, according to Raymond Vennare, Chief Executive Officer and Chairman of the Board of Predictive Oncology.

看，我不是財務大師，但是通過預測腫瘤學的這一舉動似乎很聰明。通過將數字資產集成到他們的戰略中，他們不僅要跟上時代；他們在鋪路。當然，這是一個大膽的賭注，但是可以徹底改變癌症研究。當您在盒子外面思考時，就會發生這種情況！首席執行官兼預測性腫瘤學委員會首席執行官兼董事長雷蒙德·維納爾（Raymond Vennare）表示，看到他們如何建立瞭如何建立一種結構，該結構可以通過其計劃的ATH代幣持有，以使預測性腫瘤學通過其計劃的持有量參與Aethir生態系統。

The Future is Now

未來現在是

So, what does this all mean? It means cancer research is entering a new era, one where digital assets and AI play a crucial role. It means Predictive Oncology is a company to watch. And it means that, just maybe, we're one step closer to kicking cancer's butt. Isn't that something to smile about?

那麼，這全是什麼意思？這意味著癌症研究正在進入一個新時代，其中數字資產和人工智能發揮了至關重要的作用。這意味著預測腫瘤學是一家值得關注的公司。這意味著，也許我們離踢癌症的屁股更近了一步。那不是要微笑嗎？